Breaking News, Collaborations & Alliances

Lunit and CellCarta to Collaborate on AI-Enabled Digital Pathology Workflows

Biopharma teams are increasingly seeking end-to-end services pairing companion diagnostic programs with validated AI algorithms.

Author Image

By: Patrick Lavery

Content Marketing Editor

Lunit and CellCarta are starting a strategic partnership to accelerate adoption of AI-enabled digital pathology workflows. Such approaches are intended to be used across translational research, clinical trials, and companion diagnostic (CDx) programs. Lunit, headquartered in Seoul, South Korea, provides AI services for cancer diagnostics and precision oncology. Montreal-based CellCarta is a global contract research organization (CRO) laboratory to the biopharmaceutical industry. What Lunit...

Continue reading this story and get 24/7 access to Contract Pharma for FREE


Already a subscriber? Sign in

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters